ReturnsPlannerReturnsPlanner
Quarterly Results
IPO Analysis
CalculatorsEditorial
IPO Season

IPO Analysis

GMP, subscription data, financials, and comprehensive institutional review.

Bagmane Prime Office REIT IPO: GMP, Price Band, Financials — Should You Apply?
Latest IPO
IPO Analysis4 min read

Bagmane Prime Office REIT IPO: GMP, Price Band, Financials — Should You Apply?

Bagmane Prime Office REIT is currently accepting bids with a price range of ₹95 to ₹100, showing initial interest as it nears its closing date.

ReturnsPlanner Research Team2026-05-06
Read analysis
Value 360 Communications IPO: GMP, Financials — Should You Apply?

Value 360 Communications IPO: GMP, Financials — Should You Apply?

Value 360 Communications IPO is open for bidding, showing strong initial interest with a subscription of 1.19x. Here is our analysis on the price band and risks.

ReturnsPlanner Research Team2026-05-06
JNK India IPO: GMP, Price Band, Financials — Is This the Atmanirbhar Bharat Play?

JNK India IPO: GMP, Price Band, Financials — Is This the Atmanirbhar Bharat Play?

JNK India has launched its IPO with a strong Grey Market Premium (GMP) and attractive pricing, positioning itself perfectly to capitalize on India's domestic manufacturing renaissance.

ReturnsPlanner Research Team2026-05-05
TABP Snacks IPO: Financials, Growth Drivers & Valuations — Is ₹800 Cr Target Worth It?

TABP Snacks IPO: Financials, Growth Drivers & Valuations — Is ₹800 Cr Target Worth It?

TABP Snacks, currently at a ₹208 crore topline, has ambitious plans to reach ₹800 crore in the next three years before seeking an IPO.

ReturnsPlanner Research Team2026-05-03

SEBI Compliance & Disclaimer

All IPO analysis on ReturnsPlanner is for informational purposes only. We provide data-driven insights based on Red Herring Prospectus (RHP) filings, grey market trends, and historical performance. ReturnsPlanner does NOT provide investment recommendations or "Subscribe/Avoid" calls. Investing in IPOs involves significant market risk. Please consult a SEBI-registered Investment Advisor before making any investment decisions.

© 2026 ReturnsPlanner Research. All rights reserved.